Fedora Pharmaceuticals
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
11629-105 Ave, Edmonton, Alberta, T5H 0L...Phone Number
(780) 757-5401Website
www.fedorapharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Fedora Pharmaceuticals
Fedora Pharmaceuticals Inc. is focused on the discovery and development of innovative antimicrobial drug candidates to combat antimicrobial resistance (AMR). The company seeks to establish partnerships and licensing agreements with both industry and academia to enhance its product pipeline. Their primary clients include pharmaceutical companies and research institutions interested in antimicrobial solutions. Fedora is committed to improving health through its novel approaches in drug development.Explore more
Fedora Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fedora Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Fedora Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Fedora Pharmaceuticals launches new products
Click to see if Fedora Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Fedora Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Fedora Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Fedora Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Fedora Pharmaceuticals
Check out if Fedora Pharmaceuticals is spiking on competitors!
Recommended Actions
Find VP level buyers at Fedora Pharmaceuticals
Find more new buyers
Compare Similar Companies to Fedora Pharmaceuticals
Compare insights from companies similar to Fedora Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Fedora Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Fedora Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Fedora Pharmaceuticals.
Fedora Pharmaceuticals Tech Stack
A closer look at the technologies used by Fedora Pharmaceuticals
Fedora Pharmaceuticals News & Media
Fedora Pharmaceuticals Presentations at 2026 ESCMID Highlight Safety and Potent Bactericidal Activity of FPI-2119
Potent antibacterial activity against Gram-negative community and hospital-acquired infections highlighted across eight posters and two presentationS Potent antibacterial activity against Gram-negative community and hospital-acquired infections highlighted across eight posters and two presentationSFedora Pharmaceuticals Showcasing Antibiotic Candidate at 2026 European Society of Clinical Microbiology and Infectious Diseases Congress
EDMONTON, Alberta , April 09, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, intends to present a full suite of preclinical findings from the company’s lead candidate, FPI-2119 at the upcoming European Society of Clinical Microbiology and Infectious Diseases Congress (ESCMID) congress in Munich, Germany.Fedora Pharmaceuticals Highlights Efficacy of Novel Antibiotic, FPI-2119, against Antimicrobial-resistant Gram-negative Bacteria at the 2026 IMARI Conference
FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infections FPI-2119 offers potential solution to multi-drug-resistant Gram-negative infectionsFedora Pharmaceuticals has Re-emerged to Unveil Novel Class of Antibiotics at 2026 Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI)
Edmonton, Alberta, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the company’s lead candidate at the upcoming Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) conference. IMARI was launched in May 2025 by the American Society for Microbiology (ASM) and the Infectious Diseases Society of America (IDSA) as a forum for advancing the science of antimi
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Fedora Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Fedora Pharmaceuticals Inc. is focused on the discovery and development of innovative antimicrobial drug candidates to combat antimicrobial resistance (AMR). The company seeks to establish partnerships and licensing agreements with both industry and academia to enhance its product pipeline. Their primary clients include pharmaceutical companies and... Read More
